Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.i.d. in asthma patients: a 12-week pilot study
Open Access
- 1 May 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 013-022
- https://doi.org/10.29328/journal.jprr.1001004
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- 1-year prospective real life monitoring of asthma control and quality of life in ItalyRespiratory Research, 2012
- Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trialRespiratory Medicine, 2012
- Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trialRespiratory Medicine, 2012
- Real-life prospective study on asthma control in Italy: Cross-sectional phase resultsRespiratory Medicine, 2012
- Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trialBMC Pulmonary Medicine, 2011
- Cough Due to Asthma, Cough-Variant Asthma and Non-Asthmatic Eosinophilic BronchitisOtolaryngologic Clinics of North America, 2010
- Methacholine dry powder inhaler as a new tool for bronchial challenge testInternational Journal of Pharmaceutics, 2008
- Maintenance and symptom relief with budesonide plus formoterol reduced severe asthma exacerbationsEvidence-Based Nursing, 2005
- Development of the asthma control test: A survey for assessing asthma controlJournal of Allergy and Clinical Immunology, 2004
- Cytokine modulators as novel therapies for airway diseaseEuropean Respiratory Journal, 2001